Vasileios Alexandros Karakousis

Dr. Vasileios Alexandros Karakousis

orcid

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 January 2010 in Pharmacy World & Science
Verified
Journal Article
Closed access
PDF file
ACAnna Chatsisvili
Anna Chatsisvili
ISIoakeim Sapounidis
Ioakeim Sapounidis
GPGeorgia Pavlidou
Georgia Pavlidou
EZEudoxia Zoumpouridou
Eudoxia Zoumpouridou
Vasileios Alexandros KarakousisVasileios Alexandros Karakousis
Vasileios Alexandros Karakousis
INIoannis Niopas
Ioannis Niopas

16 January 2024 in Frontiers in Immunology
Verified
Journal Article
Open access
TKTheodora Katopodi
Theodora Katopodi
SPsavvas petanidis
savvas petanidis
DADoxakis Anestakis
Doxakis Anestakis
CCCharalampos Charalampidis
Charalampos Charalampidis
ICIoanna Chatziprodromidou
Ioanna Chatziprodromidou
CKChristoforos Kosmidis
Christoforos Kosmidis
A significant factor in the antitumor immune response is the increased metabolic reprogramming of immunological and malignant cells. Increasing data points to the fact that cancer metabolism affects not just cancer signaling, which is essential for maintaining carcinogenesis and survival, but also the expression of immune cells and immune-related factors such as lactate, PGE2, arginine, IDO, which regulate the antitumor immune signaling mechanism. In reality, this energetic interaction between the immune system and the tumor results in metabolic competition in the tumor ecosystem, limiting the amount of nutrients available and causing microenvironmental acidosis, which impairs the ability of immune cells to operate. More intriguingly, different types of immune cells use metabolic reprogramming to keep the body and self in a state of homeostasis. The process of immune cell proliferation, differentiation, and performance of effector functions, which is crucial to the immune response, are currently being linked to metabolic reprogramming. Here, we cover the regulation of the antitumor immune response by metabolic reprogramming in cancer cells and immune cells as well as potential strategies for metabolic pathway targeting in the context of anticancer immunotherapy. We also discuss prospective immunotherapy-metabolic intervention combinations that might be utilized to maximize the effectiveness of current immunotherapy regimes.

3 September 2023 in Diagnostics
Verified
Journal Article
Open access
PDF file
NVNikolaos Varsamis
Nikolaos Varsamis
CKChristoforos S. Kosmidis
Christoforos S. Kosmidis
GCGrigorios Chatzimavroudis
Grigorios Chatzimavroudis
FKFani Apostolidou Kiouti
Fani Apostolidou Kiouti
CEChristoforos Efthymiadis
Christoforos Efthymiadis
IKIsaak Kesisoglou
Isaak Kesisoglou
Background: we designed a prospective study of diagnostic accuracy that compared pelvic MRI and 3D-EAUS with pelvic MRI alone in the preoperative evaluation and postoperative outcomes of patients with perianal fistulas. Methods: the sample size was 72 patients and this was divided into two imaging groups. MRI alone was performed on the first group. Both MRI and 3D-EAUS were performed in parallel on the second group. Surgical exploration took place after two weeks and was the standard reference. Park’s classification, the presence of a concomitant abscess or a secondary tract, and the location of the internal opening were recorded. All patients were re-evaluated for complete fistula healing and fecal incontinence six months postoperatively. All of the collected data were subjected to statistical analysis. Results: the MRI group included 36 patients with 42 fistulas. The MRI + 3D-EAUS group included 36 patients with 46 fistulas. The adjusted sensitivity and negative predictive value were 1.00 for most fistula types in the group that underwent combined imaging. The adjusted specificity improved for intersphincteric fistulas in the same group. The adjusted balanced accuracy improved for all fistula types except rectovaginal. The combination of imaging methods showed improved diagnostic accuracy only in the detection of a secondary tract. The healing rate at six months was 100%. Fecal incontinence at six months did not present a statistically significant difference between the two groups (Fisher’s exact test p-value > 0.9). Patients with complex perianal fistulas had a statistically significant higher probability of undergoing a second surgery (x2 test p-value = 0.019). Conclusions: the combination of pelvic MRI and 3D-EAUS showed improved metrics of diagnostic accuracy and should be used in the preoperative evaluation of all patients with perianal fistulas, especially those with complex types.

25 March 2024 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
TKTHEODORA KATOPODI
THEODORA KATOPODI
SPsavvas petanidis
savvas petanidis
EGEirini Grigoriadou
Eirini Grigoriadou
DADoxakis Anestakis
Doxakis Anestakis
CCCharalampos Charalampidis
Charalampos Charalampidis
CKChristoforos S. Kosmidis
Christoforos S. Kosmidis
Extensive research into mRNA vaccines for cancer therapy in preclinical and clinical trials has prepared the ground for the quick development of immune-specific mRNA vaccines during the COVID-19 pandemic. Therapeutic cancer vaccines based on mRNA are well tolerated, and are an attractive choice for future cancer immunotherapy. Ideal personalized tumor-dependent mRNA vaccines could stimulate both humoral and cellular immunity by overcoming cancer-induced immune suppression and tumor relapse. The stability, structure, and distribution strategies of mRNA-based vaccines have been improved by technological innovations, and patients with diverse tumor types are now being enrolled in numerous clinical trials investigating mRNA vaccine therapy. Despite the fact that therapeutic mRNA-based cancer vaccines have not yet received clinical approval, early clinical trials with mRNA vaccines as monotherapy and in conjunction with checkpoint inhibitors have shown promising results. In this review, we analyze the most recent clinical developments in mRNA-based cancer vaccines and discuss the optimal platforms for the creation of mRNA vaccines. We also discuss the development of the cancer vaccines’ clinical research, paying particular attention to their clinical use and therapeutic efficacy, which could facilitate the design of mRNA-based vaccines in the near future.

10 June 2025 in Cancers
Verified
Journal Article
Open access
PDF file
SMSTYLIANOS MANTALOVAS
STYLIANOS MANTALOVAS
Vasileios Alexandros KarakousisVasileios Alexandros Karakousis
Vasileios Alexandros Karakousis
CSChristina Sevva
Christina Sevva
PRPanagiota Roulia
Panagiota Roulia
SSStavros Savvakis
Stavros Savvakis
IKIsaak Kesisoglou
Isaak Kesisoglou
Background/Objectives: The present investigation quantifies the striking predisposition for small intestinal GISTs in NF-1 patients, examining both multifocal and solitary tumor patterns while establishing critical epidemiological comparisons with the general population. By elucidating these distinct clinical and biological profiles, the study aims to transform the understanding of NF1-associated tumorigenesis and optimize patient surveillance strategies. Methods: This systematic review and meta-analysis was conducted in strict accordance with PRISMA guidelines, the gold-standard framework for minimizing bias and maximizing reproducibility in evidence synthesis. Prospectively registered in PROSPERO, the study employed a PICO framework to evaluate interventions, outcomes, and comparisons. Results: This systematic review and meta-analysis reveals a profound oncogenic propensity for small intestinal GISTs in NF-1 patients, demonstrating markedly increased prevalence relative to population baselines. The tumors display characteristic presentation and histological profiles, with a distribution of 54% multifocal lesions, 41% solitary SI-GIST, and 5% solitary duodenal GIST cases, demonstrating the diverse clinical manifestations of NF-1-associated tumors. These compelling findings not only redefine the epidemiological landscape of NF1-associated malignancies but also underscore extraordinary disease susceptibility, far surpassing previous estimates and sporadic occurrence rates in the general population. Conclusions: The distinct clinical patterns and high frequency of these tumors among NF-1 patients provide important insights into GIST development while underscoring the need for heightened clinical suspicion, particularly in patients manifesting gastrointestinal hemorrhage. These findings highlight the unique challenges in managing these cases—including diagnostic limitations and therapeutic constraints—underscoring the imperative for multidisciplinary therapeutic frameworks for detection, monitoring and treatment in this high-risk population.

19 December 2024 in Cancers
Verified
Journal Article
Open access
PDF file
KPKonstantinos Papadopoulos
Konstantinos Papadopoulos
Ioannis IakovouIoannis Iakovou
Ioannis Iakovou
SMSTYLIANOS MANTALOVAS
STYLIANOS MANTALOVAS
CKChristoforos S. Kosmidis
Christoforos S. Kosmidis
Stiliani Konstantinos LaskouStiliani Konstantinos Laskou
Stiliani Konstantinos Laskou
KSKonstantinos Sapalidis
Konstantinos Sapalidis
Background/Objectives: Medullary thyroid carcinoma (MTC) is a highly aggressive tumor, as it is characterized by a high probability of local recurrence and distant metastases, even after surgical treatment. Early detection of disease recurrence is critical for improving long-term treatment outcomes and overall patient survival. By comparing different radiopharmaceuticals, this analysis aimed to strengthen existing guidelines and help bridge the gap between the recommendations of the ESMO and the ATA, highlighting the importance of PET/CT scanning in the postoperative follow-up of patients with MTC. Methods: This research was carried out using three searchable databases, PubMed, ScienceDirect, and ResearchGate, resulting in 575 bibliographic studies up to the date of 20 June 2024. A meta-analysis of diagnostic accuracy was performed using the software Meta—DiSc, Version: 2.0 (Universidad Complutense, Barcelona, Spain), which led to aggregate assessments and the design of the SROC. Results: A quality assessment of the eligible studies was conducted, and the key findings were summarized. Conclusions: Regardless of methodology, PET/CT scanning exhibits high sensitivity and specificity values in the diagnosis of local recurrence and metastases in surgical patients with medullary thyroid carcinoma. Furthermore, based on a comparative analysis of18F-FDG and GA68-DOTATE, it appears that these misunderstood radiopharmaceuticals are particularly sensitive and reliable for highlighting MTC, and it was found that there were no statistical differences in terms of sensitivity and specificity. Therefore, these two modalities appear to be complementary in monitoring MTC patients.